Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Journal of the American Chemical Society|October 19, 2006
Total synthesis of (+)-cis-sylvaticin: double oxidative cyclization reactions catalyzed by osmiumTimothy J Donohoe, Robert M Harris, Jeremy Burrows, et al.Journal of the American Chemical Society|August 14, 2009
Concise syntheses of the natural products (+)-sylvaticin and (+)-cis-sylvaticinTimothy J Donohoe, Robert M Harris, Oliver Williams, et al.The British Journal of Psychiatry : the Journal of Mental Science|August 9, 2019
Estimating local need for mental healthcare to inform fair resource allocation in the NHS in England: cross-sectional analysis of national administrative data linked at person levelLaura Anselmi, Anna Everton, Robert Shaw, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Identification and In-Vitro ADME Assessment of a Series of Novel Anti-Malarial Agents Suitable for Hit-to-Lead ChemistryChris D Edlin, Garreth Morgans, Susan Winks, et al.Biochemical Pharmacology|July 7, 2022
Multistage and transmission-blocking tubulin targeting potent antimalarial discovered from the open access MMV pathogen boxGeeta Kumari, Ravi Jain, Raj Kumar Sah, et al.Malaria Journal|December 12, 2018
A discovery and development roadmap for new endectocidal transmission-blocking agents in malariaJeremy Burrows, Hannah Slater, Fiona Macintyre, et al.Scientific Reports|December 17, 2017
Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmissionKoen J Dechering, Hans-Peter Duerr, Karin M J Koolen, et al.Plos Neglected Tropical Diseases|February 4, 2022
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetomaWilson Lim, Bertrand Nyuykonge, Kimberly Eadie, et al.Journal of Chemical Information and Modeling|March 4, 2017
Shared Consensus Machine Learning Models for Predicting Blood Stage Malaria InhibitionAndreas Verras, Chris L Waller, Peter Gedeck, et al.ACS Medicinal Chemistry Letters|June 6, 2014
A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial ScaffoldFélix Calderón, Jaume Vidal-Mas, Jeremy Burrows, et al.Pageof 3